Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A malignant neoplasm of the ovary with an invasive epithelial component and a fibrotic stroma. The epithelial component is characterized by the presence of malignant epithelial cells with intracytoplasmic mucin. Cystic spaces are also present which contain mucoid material.
Biomarker and diagnostic research for ovarian mucinous adenocarcinofibroma has been reported in the published literature.
No clinical trials have been registered for ovarian mucinous adenocarcinofibroma.
1 publication has been identified in PubMed for ovarian mucinous adenocarcinofibroma. Research spans Diagnostic / Biomarker (100%).
Miyama Y (2024). [PMID: 38870078](https://pubmed.ncbi.nlm.nih.gov/38870078/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 8:43 AM UTC